Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection.

Aviles H, O'Donnell P, Orshal J, Fujii H, Sun B, Sonnenfeld G.

Am J Surg. 2008 Apr;195(4):537-45. doi: 10.1016/j.amjsurg.2007.05.045.

PMID:
18304499
2.

Active hexose correlated compound (AHCC) enhances resistance to infection in a mouse model of surgical wound infection.

Aviles H, O'Donnell P, Sun B, Sonnenfeld G.

Surg Infect (Larchmt). 2006 Dec;7(6):527-35.

PMID:
17233570
3.

Active hexose correlated compound enhances resistance to Klebsiella pneumoniae infection in mice in the hindlimb-unloading model of spaceflight conditions.

Aviles H, Belay T, Fountain K, Vance M, Sun B, Sonnenfeld G.

J Appl Physiol (1985). 2003 Aug;95(2):491-6. Epub 2003 Apr 11.

4.
5.

Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.

Nogusa S, Gerbino J, Ritz BW.

Nutr Res. 2009 Feb;29(2):139-43. doi: 10.1016/j.nutres.2009.01.005.

PMID:
19285605
6.

Infectivity of hepatic strain Klebsiella pneumoniae in diabetic mice.

Wu JH, Tsai CG.

Exp Biol Med (Maywood). 2005 Nov;230(10):757-61.

PMID:
16246903
7.

Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis.

Lenz AM, Franklin GA, Fairweather M, McClintock ML, Jala VR, Peyton JC, Gardner SA, Cheadle WG.

Cytokine. 2007 Dec;40(3):207-15. Epub 2007 Nov 28.

PMID:
18053738
8.

Effects of ethanol on cytokine production after surgery in a murine model of gram-negative pneumonia.

Spies CD, Lanzke N, Schlichting U, Muehlbauer S, Pipolo C, von Mettenheim M, Lehmann A, Morawietz L, Nattermann H, Sander M.

Alcohol Clin Exp Res. 2008 Feb;32(2):331-8. Epub 2007 Dec 20.

PMID:
18162079
9.

Supplementation with active hexose correlated compound increases survival following infectious challenge in mice.

Ritz BW.

Nutr Rev. 2008 Sep;66(9):526-31. doi: 10.1111/j.1753-4887.2008.00085.x. Review.

PMID:
18752476
10.

Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens.

Cooper JM, Rowley D.

Aust J Exp Biol Med Sci. 1982 Dec;60(6):629-41.

PMID:
6820634
11.

The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.

Hirose A, Sato E, Fujii H, Sun B, Nishioka H, Aruoma OI.

Toxicol Appl Pharmacol. 2007 Jul 15;222(2):152-8. Epub 2007 Apr 20.

PMID:
17555784
13.

Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial.

Terakawa N, Matsui Y, Satoi S, Yanagimoto H, Takahashi K, Yamamoto T, Yamao J, Takai S, Kwon AH, Kamiyama Y.

Nutr Cancer. 2008;60(5):643-51. doi: 10.1080/01635580801993280.

PMID:
18791928
14.

Active hexose correlated compound enhances the immune function of mice in the hindlimb-unloading model of spaceflight conditions.

Aviles H, Belay T, Vance M, Sun B, Sonnenfeld G.

J Appl Physiol (1985). 2004 Oct;97(4):1437-44. Epub 2004 Jun 11.

15.

Alleviating effect of active hexose correlated compound (AHCC) for anticancer drug-induced side effects in non-tumor-bearing mice.

Shigama K, Nakaya A, Wakame K, Nishioka H, Fujii H.

J Exp Ther Oncol. 2009;8(1):43-51.

PMID:
19827270
16.

Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice.

Wang S, Welte T, Fang H, Chang GJ, Born WK, O'Brien RL, Sun B, Fujii H, Kosuna K, Wang T.

J Nutr. 2009 Mar;139(3):598-602. doi: 10.3945/jn.108.100297. Epub 2009 Jan 13.

17.

Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model.

Ignacio RM, Kim CS, Kim YD, Lee HM, Qi XF, Kim SK.

Cytokine. 2015 Dec;76(2):131-7. doi: 10.1016/j.cyto.2015.06.002. Epub 2015 Jun 13.

PMID:
26082022
18.

Proinflammatory cytokines in antilipopolysaccharide immunity against Klebsiella infections.

Rukavina T, Vasiljev V, Ticac B.

Mediators Inflamm. 2005 Jun 9;2005(2):88-95.

19.

Particle size determines activation of the innate immune system in the lung.

Samuelsen M, Nygaard UC, Løvik M.

Scand J Immunol. 2009 May;69(5):421-8. doi: 10.1111/j.1365-3083.2009.02244.x. Epub 2009 Feb 26.

20.

Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.

Inoue K, Shiota S, Yamada K, Gotoh K, Suganuma M, Fujioka T, Ahmed K, Iha H, Nishizono A.

Helicobacter. 2009 Oct;14(5):135-43. doi: 10.1111/j.1523-5378.2009.00713.x.

PMID:
19751439

Supplemental Content

Support Center